Diligent incubated this startup and provided system design, electronics design, optical design, mechanical design and software design for this complex electro-optical device designed to measure fluorescence in the lens of the human for the purpose of detecting signs of diabetes. 

Diligent managed eye safety analysis, applied for and obtained IRB approval and conducted limited human trials in our facilities.